RU93055556A - DRUG FOR TREATMENT OF MASTITA OF CATTLE "LIZOMAST" - Google Patents

DRUG FOR TREATMENT OF MASTITA OF CATTLE "LIZOMAST"

Info

Publication number
RU93055556A
RU93055556A RU93055556/15A RU93055556A RU93055556A RU 93055556 A RU93055556 A RU 93055556A RU 93055556/15 A RU93055556/15 A RU 93055556/15A RU 93055556 A RU93055556 A RU 93055556A RU 93055556 A RU93055556 A RU 93055556A
Authority
RU
Russia
Prior art keywords
cattle
treatment
drug
mastita
lizomast
Prior art date
Application number
RU93055556/15A
Other languages
Russian (ru)
Other versions
RU2064299C1 (en
Inventor
В.М. Карташова
Л.Д. Демидова
И.С. Кулаев
А.Г. Козловский
В.А. Ежов
А.И. Северин
В.И. Крупянко
Original Assignee
Всероссийский научно-исследовательский институт ветеринарной санитарии, гигиены и экологии
Институт биохимии и физиологии микроорганизмов РАН
Filing date
Publication date
Application filed by Всероссийский научно-исследовательский институт ветеринарной санитарии, гигиены и экологии, Институт биохимии и физиологии микроорганизмов РАН filed Critical Всероссийский научно-исследовательский институт ветеринарной санитарии, гигиены и экологии
Priority to RU93055556A priority Critical patent/RU2064299C1/en
Priority claimed from RU93055556A external-priority patent/RU2064299C1/en
Application granted granted Critical
Publication of RU2064299C1 publication Critical patent/RU2064299C1/en
Publication of RU93055556A publication Critical patent/RU93055556A/en

Links

Claims (1)

Использование: в сельском хозяйстве, ветеринарии. Сущность изобретения: для лечения мастита крупного рогатого скота предлагается препарат, содержащий комплекс бактериолитических ферментов. Препарат в качестве комплекса бактериолитических ферментов содержит лизоамидазу, дополнительно содержит одно- и двузамещенный фосфорнокислый натрий при следующем соотношении компонентов, мас.%: лизоамидаза 55 - 70, фосфорнокислый однозамещенный натрий 0,2 - 1,0, фосфорнокислый двузамещенный натрий остальное. Препарат содержит лизоамидазу с активностью 10-100 ЛЕ/мг.Usage: in agriculture, veterinary medicine. The essence of the invention: for the treatment of mastitis in cattle, a preparation is proposed containing a complex of bacteriolytic enzymes. The preparation as a complex of bacteriolytic enzymes contains lysoamidase, additionally contains mono- and disubstituted sodium phosphate in the following ratio of components, wt.%: Lysoamidase 55 - 70, sodium phosphate monosubstituted 0.2 - 1.0, sodium phosphate disubstituted the rest. The drug contains lysoamidase with an activity of 10-100 LU / mg.
RU93055556A 1993-12-13 1993-12-13 Preparation for medical treatment of mastitis of horned cattle RU2064299C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU93055556A RU2064299C1 (en) 1993-12-13 1993-12-13 Preparation for medical treatment of mastitis of horned cattle

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU93055556A RU2064299C1 (en) 1993-12-13 1993-12-13 Preparation for medical treatment of mastitis of horned cattle

Publications (2)

Publication Number Publication Date
RU2064299C1 RU2064299C1 (en) 1996-07-27
RU93055556A true RU93055556A (en) 1997-02-20

Family

ID=20150227

Family Applications (1)

Application Number Title Priority Date Filing Date
RU93055556A RU2064299C1 (en) 1993-12-13 1993-12-13 Preparation for medical treatment of mastitis of horned cattle

Country Status (1)

Country Link
RU (1) RU2064299C1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6428784B1 (en) 1997-10-31 2002-08-06 New Horizons Diagnostics Corp Vaginal suppository for treating group B Streptococcus infection
US6056955A (en) * 1999-09-14 2000-05-02 Fischetti; Vincent Topical treatment of streptococcal infections

Similar Documents

Publication Publication Date Title
EP0427247A3 (en) Pharmaceutical composition with r-alpha-lipoic acid or s-alpha-lipoic acid as the active ingredient
IT8667657A1 (en) DISPENSING DEVICE FOR THE ADMINISTRATION OF A BENEFICIAL AGENT TO THE ENVIRONMENT OF USE PARTICULARLY FOR THE ADMINISTRATION OF A THERAPEUTIC AGENT TO A RUMINANT ANIMAL.
CA2122612A1 (en) Pharmaceutical products for curing tumourous diseases and process for preparing same
MY101791A (en) New benzimidazole derivatives
GR3007043T3 (en)
JPS57212114A (en) Capsule containing allergen activator and preparation therefor
TW234691B (en)
IE873125L (en) Benzimidazole derivatives
TR199701294T1 (en) Composition consisting of amoxicillin and clavulanic acid.
RU93032613A (en) PHARMACEUTICAL PREPARATION FOR THE TREATMENT OF PATIENTS WITH PROLONGED COAGULATION TIME, METHOD OF TREATING PATIENTS, USING THE EPI INHIBITOR FOR OBTAINING THE PHARMACEUTICAL PREPARATION
GR3019514T3 (en) Pharmaceutical preparation for the treatment of prolonged coagulation time
ZA964035B (en) Fluorophenyl-substituted alkenylcarboxylic acid guanidides, process for their preparation, their use as a medicament or diagnostic, and medicament containing them.
AU591046B2 (en) Physiologically active agent for agricultural use
RU93055556A (en) DRUG FOR TREATMENT OF MASTITA OF CATTLE "LIZOMAST"
CA2283739A1 (en) Ascorbic acid as an adjuvant in treatment of malignant tumors by chemotherapy and radiotherapy
GR3026590T3 (en) Antibiotics ge 37468 a, b and c.
CA2018227A1 (en) Association of physiologically dosed vitamin a and of various active principles having a therapeutical activity
IE45136L (en) Rearing of animals
EP0227356A3 (en) The use of depogen in the treatment of restricted blood circulation
DK1019037T3 (en) Drug containing delta-aminolevulinic acid
NO304518B1 (en) Benzimidazoles, their use for the manufacture of a medicament, and pharmaceutical preparations comprising them
EP0418065A3 (en) Dihydrocaffeic acid derivatives, use thereof for medical treatments and pharmaceutical preparations containing same
RU94016574A (en) PREPARATION FOR THE TREATMENT AND PREVENTION OF MASTITARY CATTLE MASTITIS IN A DRY PERIOD
Olay et al. Experimental Staphylococcus aureus osteomyelitis treated with fosfomycin and cephazolin: Single and combined therapy.
IE780730L (en) Veterinary composition